Gene · 2296
Papers3,080
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
601 to 620 of 3,080
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Genotype-phenotype association of PITX2 and FOXC1 in Axenfeld-Rieger syndrome. | Exp Eye Res | 2023 | 36442680 | PubTator, text mining | PubMed |
| LCK, FOXC1 and hsa-miR-146a-5p as potential immune effector molecules associated with rheumatoid arthritis. | Biomarkers | 2023 | 36420648 | PubTator, text mining | PubMed |
| Single-cell RNA-seq analysis to identify potential biomarkers for diagnosis, and prognosis of non-small cell lung cancer by using comprehensive bioinformatics approaches. | Transl Oncol | 2023 | 36401966 | PubTator, text mining | PubMed |
| Triple-Negative PAM50 Non-Basal Breast Cancer Subtype Predicts Benefit from Extended Adjuvant Capecitabine. | Clin Cancer Res | 2023 | 36346687 | PubTator, text mining | PubMed |
| The imminent role of microRNAs in salivary adenoid cystic carcinoma. | Transl Oncol | 2023 | 36335706 | PubTator, text mining | PubMed |
| Downregulation of iNOS/NO Promotes Epithelial-Mesenchymal Transition and Metastasis in Colorectal Cancer. | Mol Cancer Res | 2023 | 36306210 | PubTator, text mining | PubMed |
| Targeting Transcription Factors in Cancer: From "Undruggable" to "Druggable". | Methods Mol Biol | 2023 | 36264492 | PubTator, text mining | PubMed |
| High frequency of HTRA1 AND ABCC6 mutations in Japanese patients with adult-onset cerebral small vessel disease. | J Neurol Neurosurg Psychiatry | 2023 | 36261288 | PubTator, text mining | PubMed |
| Tinengotinib (TT-00420), a Novel Spectrum-Selective Small-Molecule Kinase Inhibitor, Is Highly Active Against Triple-Negative Breast Cancer. | Mol Cancer Ther | 2023 | 36223547 | PubTator, text mining | PubMed |
| Designing a novel SOX9 based multi-epitope vaccine to combat metastatic triple-negative breast cancer using immunoinformatics approach. | Mol Divers | 2023 | 36214961 | PubTator, text mining | PubMed |
| Genetic variation in NFE2L2 is associated with outcome following aneurysmal subarachnoid haemorrhage. | Eur J Neurol | 2023 | 36148820 | PubTator, text mining | PubMed |
| YAP 5-methylcytosine modification increases its mRNA stability and promotes the transcription of exosome secretion-related genes in lung adenocarcinoma. | Cancer Gene Ther | 2023 | 36123390 | PubTator, text mining | PubMed |
| Network-Based Data Analysis Reveals Ion Channel-Related Gene Features in COVID-19: A Bioinformatic Approach. | Biochem Genet | 2023 | 36104591 | PubTator, text mining | PubMed |
| Homology modeling of Forkhead box protein C2: identification of potential inhibitors using ligand and structure-based virtual screening. | Mol Divers | 2023 | 36048303 | PubTator, text mining | PubMed |
| Axenfeld-Rieger syndrome: more than meets the eye. | J Med Genet | 2023 | 35882526 | PubTator, text mining | PubMed |
| Construction of a prognostic glycolysis-related lncRNA signature for patients with colorectal cancer. | Cancer Med | 2023 | 35616307 | PubTator, text mining | PubMed |
| Podocyte-specific Transcription Factors: Could MafB Become a Therapeutic Target for Kidney Disease? | Intern Med | 2023 | 35249929 | PubTator, text mining | PubMed |
| Differential epitranscriptome and proteome modulation in the brain of neonatal mice exposed to isoflurane or sevoflurane. | Cell Biol Toxicol | 2023 | 35249202 | PubTator, text mining | PubMed |
| Ocular and Systemic Factors Associated with Glaucoma. | J Curr Glaucoma Pract | 2022 | 36793269 | PubTator, text mining | PubMed |
| DDR2 coordinates EMT and metabolic reprogramming as a shared effector of FOXQ1 and SNAI1. | Cancer Res Commun | 2022 | 36713812 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2296/papers?page=31